EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹41 Cr | ₹-60 Cr | ₹-73 Cr | ₹-108 Cr | ₹-157 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹41 Cr |
Mar2023 | ₹-60 Cr |
Mar2022 | ₹-73 Cr |
Mar2021 | ₹-108 Cr |
Mar2020 | ₹-157 Cr |
How is Deferred Tax Assets / Liabilities of EMCURE PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹41 Cr | Positive | |
Mar2023 | ₹-60 Cr | Negative | |
Mar2022 | ₹-73 Cr | Negative | |
Mar2021 | ₹-108 Cr | Negative | |
Mar2020 | ₹-157 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹26,635.2 Cr | 3.5% | 6.6% | 8.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 3.5% |
6.6% |
8.9% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses